31 search results for: biologics

Should we Still Operate on Patients With Chronic Rhinosinusitis With Nasal Polyps?
Rhinology
Should we Still Operate on Patients With Chronic Rhinosinusitis With Nasal Polyps?
expert video

This video clip from the EAACI 2024 symposium discusses whether patients with CRSwNP should undergo a surgery.

View more
Can Chronic Rhinosinusitis With Nasal Polyps be Considered in Remission if the Patient has an Impaired Sense of Smell?
Rhinology
Can Chronic Rhinosinusitis With Nasal Polyps be Considered in Remission if the Patient has an Impaired Sense of Smell?
expert video

Dr. Backer discusses assessing remission in CRSwNP by evaluating the patient's sense of smell in this video clip from the EAACI 2024 symposium.

View more
When is the right time to consider a biologic in patients with CRSwNP?
Rhinology
When is the right time to consider a biologic in patients with CRSwNP?
expert video

Prof. Hellings and Prof. Corso explain that the right time to implement a biologic depends on academic and reimbursement criteria, which vary by country.

View more
What treatments may be needed to achieve remission? And In what percentage of patients could remission be a target?
Rhinology
What treatments may be needed to achieve remission? And In what percentage of patients could remission be a target?
expert video

Prof. Hellings and Prof. Corso highlight that disease severity plays a key role in rate and control of remission in CRS.

View more
Why did the definition of control in CRSwNP change between EPOS 2020 and EPOS/EUFOREA 2024?
Rhinology
Why did the definition of control in CRSwNP change between EPOS 2020 and EPOS/EUFOREA 2024?
expert video

Prof. Hellings and Prof. Corso discuss the significance and rationale behind the new definition of CRSwNP.

View more
Urticaria Centers of Reference and Excellence (UCARE) 2023 | São Paulo
Congress
8
December
2023
Congress
Urticaria Centers of Reference and Excellence (UCARE) 2023 | São Paulo

Exploring the role of type 2 inflammation and the neuroimmune axis in CSU, and how emerging therapeutics are targeting key molecules in these pathways.

Normalizing Skin Barrier by Inhibiting IL-4 & IL-13, or IL-13 Alone
Dermatology
Normalizing Skin Barrier by Inhibiting IL-4 & IL-13, or IL-13 Alone
expert video

Dr. Ramien explores how advanced systemic therapies may modify atopic dermatitis pathomechanisms including skin barrier dysfunction, and neuroimmune dysregulation

View more
Prurigo Nodularis: The Patient Journey
Dermatology
Prurigo Nodularis: The Patient Journey
interactivity

An interactive tool highlighting the disease burden, impact and management of prurigo nodularis throughout the patient journey before diagnosis, during diagnosis and during treatment.

View more
ESPGHAN 2024 | Clinical Management of Young Children With EoE
Gastroenterology
ESPGHAN 2024 | Clinical Management of Young Children With EoE
expert video

Dr. Dhandapani Ashok highlights treatment options for patients with EoE aged 12 years and younger and the importance of shared decision-making.

View more
UEG 2025 | Current and Emerging Treatment Options in EoE
Gastroenterology
UEG 2025 | Current and Emerging Treatment Options in EoE
expert video

Prof. Greuter presents clinical data for approved treatments for adult EoE.

View more
European Academy of Allergy and Clinical Immunology (EAACI) 2023 | Hamburg
Congress
9
June
2023
Congress
European Academy of Allergy and Clinical Immunology (EAACI) 2023 | Hamburg

Presentation highlights from the ADVENT symposium at the EAACI 2023 congress in Hamburg, Germany.

ADVENT On Air | First-hand Experience: Expert Insights on the Management of Atopic Hand and Foot Dermatitis
Dermatology
ADVENT On Air | First-hand Experience: Expert Insights on the Management of Atopic Hand and Foot Dermatitis
Podcast

This podcast episode discusses best practices for the diagnosis of atopic dermatitis of the hands and feet, as well as current and emerging treatment options.

View more